These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7049208)

  • 1. Pindolol--the pharmacology of a partial agonist.
    Clark BJ; Menninger K; Bertholet A
    Br J Clin Pharmacol; 1982; 13(Suppl 2):149S-158S. PubMed ID: 7049208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pindolol on vascular smooth muscle.
    Clark BJ; Bertholet A
    Gen Pharmacol; 1983; 14(1):117-9. PubMed ID: 6826021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the ISA of pindolol beta 2-adrenoceptor selective?
    Aellig WH; Clark BJ
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):21S-28S. PubMed ID: 2894222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological studies on the intrinsic sympathomimetic activity of the beta-adrenoceptor antagonist mepindolol.
    Beckmann R; Müller B; Schröder G; Stock G
    Arzneimittelforschung; 1986 May; 36(5):811-3. PubMed ID: 2873820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of pindolol.
    Aellig WH
    Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol.
    Ishibashi T; Mitomi A; Tatebe S; Imai S
    Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of action of (-)-pindolol on feline and human myocardium.
    Kaumann AJ; Lobnig BM
    Br J Pharmacol; 1986 Sep; 89(1):207-18. PubMed ID: 2879589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of beta-adrenoceptor blocking drugs possessing partial agonist activity, with special reference to pindolol.
    Aellig WH
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S16-20. PubMed ID: 6188915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
    Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasodilating properties of beta-adrenoceptor blockers with intrinsic sympathomimetic activity.
    Thulesius O; Gjöres JE; Berlin E
    Br J Clin Pharmacol; 1982; 13(Suppl 2):229S-230S. PubMed ID: 6125174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steric aspects of agonism and antagonism at beta-adrenoceptors: experiments with the enantiomers of terbutaline and pindolol.
    Jeppsson AB; Johansson U; Waldeck B
    Acta Pharmacol Toxicol (Copenh); 1984 Apr; 54(4):285-91. PubMed ID: 6328869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do both adrenaline and noradrenaline stimulate cardiac alpha-adrenoceptors to induce positive inotropy of rat atria?
    Williamson KL; Broadley KJ
    Br J Pharmacol; 1989 Oct; 98(2):597-611. PubMed ID: 2555016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.
    Ball DI; Brittain RT; Coleman RA; Denyer LH; Jack D; Johnson M; Lunts LH; Nials AT; Sheldrick KE; Skidmore IF
    Br J Pharmacol; 1991 Nov; 104(3):665-71. PubMed ID: 1686740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sympathomimetic activity of (+/-)-pindolol at beta 1- and beta 2-adrenoceptor sites.
    Mian MA; Malta E
    Eur J Pharmacol; 1985 Feb; 109(1):65-71. PubMed ID: 2986991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.
    Farmer JB; Kennedy I; Levy GP; Marshall RJ
    Br J Pharmacol; 1972 Aug; 45(4):660-75. PubMed ID: 4404413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial agonistic properties of (+/-)-pindolol at atypical beta-adrenoceptors in the guinea pig gastric fundus.
    Horinouchi T; Koike K
    Pharmacology; 2001; 63(4):197-202. PubMed ID: 11729357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.
    Aellig WH
    Br J Clin Pharmacol; 1982; 13(Suppl 2):187S-192S. PubMed ID: 6125169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro pharmacology of xamoterol (ICI 118,587).
    Malta E; Mian MA; Raper C
    Br J Pharmacol; 1985 May; 85(1):179-87. PubMed ID: 2862938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.